Regulations and Regulatory Advocacy

AHA comments on the Centers for Medicare & Medicaid Services鈥 calendar year 2019 proposed rule for the Home Health prospective payment system.
AHA comments on the Drug Enforcement Administration鈥檚 (DEA) notice of proposed rulemaking on aggregate production quotas for Schedule I and II controlled substances.
The Department of Health and Human Services鈥 Office of Inspector General seeks comments on how it can modify the anti-kickback statute and exceptions to the beneficiary inducements civil monetary penalty definition of 鈥渞emuneration.鈥
The Centers for Medicare & Medicaid Services yesterday issued a final rule updating Medicare鈥檚 hospice payment rates, wage index and quality reporting requirements for fiscal year 2019.
The Centers for Medicare & Medicaid Services has issued corrected preview reports for the Discharge to Community measure in the Long-term Care Hospital Quality Reporting Program for review before the data is added to the LTCH Compare website in October.
House Energy and Commerce Committee leaders yesterday sent letters to nine contract pharmacies that participate in the 340B drug savings program requesting information about their participation in the program.
Effective Jan. 1, The Joint Commission will require accredited hospitals with at least 300 live births per year to report the percentage of infants with unexpected newborn complications among full-term newborns with no pre-existing conditions.